Edesa Biotech, Inc. Share-based Payment Arrangement, Expense in USD from 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Edesa Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2023 to Q2 2025.
  • Edesa Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $200K, a 100% increase year-over-year.
  • Edesa Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $500K, a 58.3% decline from 2023.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Edesa Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $200K +$100K +100% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q2 2024 $100K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08

Edesa Biotech, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $500K -$700K -58.3% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-13
2023 $1.2M Oct 1, 2022 Sep 30, 2023 10-K 2024-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.